TD Asset Management Inc boosted its stake in shares of The Sherwin-Williams Company (NYSE:SHW – Free Report) by 0.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 217,553 shares of the specialty chemicals company’s stock after acquiring an additional 454 shares during the period. TD Asset Management Inc owned 0.09% of Sherwin-Williams worth $74,699,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of SHW. Vanguard Group Inc. increased its position in shares of Sherwin-Williams by 1.1% in the first quarter. Vanguard Group Inc. now owns 22,082,544 shares of the specialty chemicals company’s stock worth $7,711,004,000 after purchasing an additional 245,896 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in Sherwin-Williams by 21.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company’s stock valued at $3,023,126,000 after buying an additional 1,505,341 shares during the period. Alliancebernstein L.P. raised its position in shares of Sherwin-Williams by 2.2% in the 1st quarter. Alliancebernstein L.P. now owns 4,409,209 shares of the specialty chemicals company’s stock valued at $1,539,652,000 after buying an additional 93,209 shares in the last quarter. PineStone Asset Management Inc. raised its position in shares of Sherwin-Williams by 12.0% in the 2nd quarter. PineStone Asset Management Inc. now owns 1,681,100 shares of the specialty chemicals company’s stock valued at $577,222,000 after buying an additional 180,616 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Sherwin-Williams by 4.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,536,398 shares of the specialty chemicals company’s stock worth $536,495,000 after acquiring an additional 64,325 shares during the period. 77.67% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
SHW has been the topic of a number of recent analyst reports. Evercore ISI lifted their price objective on shares of Sherwin-Williams from $380.00 to $400.00 and gave the company an “outperform” rating in a research note on Tuesday, August 26th. Citigroup reaffirmed a “neutral” rating and issued a $380.00 target price (up previously from $375.00) on shares of Sherwin-Williams in a report on Monday, October 6th. Mizuho lowered their price target on Sherwin-Williams from $400.00 to $385.00 and set an “outperform” rating for the company in a report on Wednesday, July 23rd. Wells Fargo & Company set a $395.00 price objective on Sherwin-Williams and gave the company an “overweight” rating in a research note on Friday, October 10th. Finally, BMO Capital Markets decreased their target price on Sherwin-Williams from $405.00 to $391.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 23rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Sherwin-Williams presently has an average rating of “Moderate Buy” and an average target price of $387.13.
Insider Buying and Selling
In other news, CAO James P. Lang sold 860 shares of Sherwin-Williams stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $350.35, for a total transaction of $301,301.00. Following the transaction, the chief accounting officer owned 377 shares in the company, valued at approximately $132,081.95. The trade was a 69.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Justin T. Binns sold 609 shares of the business’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $368.82, for a total transaction of $224,611.38. Following the completion of the sale, the insider directly owned 17,922 shares in the company, valued at approximately $6,609,992.04. This represents a 3.29% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.60% of the company’s stock.
Sherwin-Williams Trading Down 0.7%
Shares of SHW stock opened at $332.81 on Thursday. The Sherwin-Williams Company has a twelve month low of $308.84 and a twelve month high of $400.42. The stock’s fifty day simple moving average is $354.01 and its 200 day simple moving average is $348.20. The company has a quick ratio of 0.48, a current ratio of 0.78 and a debt-to-equity ratio of 1.78. The firm has a market capitalization of $82.98 billion, a P/E ratio of 33.02, a P/E/G ratio of 2.78 and a beta of 1.20.
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its earnings results on Tuesday, July 22nd. The specialty chemicals company reported $3.38 EPS for the quarter, missing the consensus estimate of $3.76 by ($0.38). The firm had revenue of $6.31 billion during the quarter, compared to the consensus estimate of $6.31 billion. Sherwin-Williams had a net margin of 11.03% and a return on equity of 66.91%. Sherwin-Williams’s revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.70 earnings per share. Sherwin-Williams has set its FY 2025 guidance at 11.200-11.500 EPS. As a group, sell-side analysts predict that The Sherwin-Williams Company will post 12 EPS for the current fiscal year.
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Articles
- Five stocks we like better than Sherwin-Williams
- Consumer Discretionary Stocks Explained
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Buy Gold Stock and Invest in Gold
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.